Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C4H7NO4 |
Molecular Weight | 133.1027 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
N[C@@H](CC(O)=O)C(O)=O
InChI
InChIKey=CKLJMWTZIZZHCS-REOHCLBHSA-N
InChI=1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)/t2-/m0/s1
Molecular Formula | C4H7NO4 |
Molecular Weight | 133.1027 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.worldcat.org/title/fundamentals-of-biochemistry-life-at-the-molecular-level/oclc/910538334Advances in Protein Chemistry (1945), v.2, p.308, retrieved from: https://books.google.ru/books?id=QRyhIaEwrngCCurator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/15703381 |
https://www.ncbi.nlm.nih.gov/pubmed/3814227 |
https://www.ncbi.nlm.nih.gov/pubmed/16061593
Sources: https://www.worldcat.org/title/fundamentals-of-biochemistry-life-at-the-molecular-level/oclc/910538334Advances in Protein Chemistry (1945), v.2, p.308, retrieved from: https://books.google.ru/books?id=QRyhIaEwrngC
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/15703381 |
https://www.ncbi.nlm.nih.gov/pubmed/3814227 |
https://www.ncbi.nlm.nih.gov/pubmed/16061593
Disodium aspartate is used in organic biosynthesis.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3814227
Curator's Comment: Aspartic acid is produced in the brain and acts as endogenous neurotransmitter.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Q7L266 Gene ID: 80150.0 Gene Symbol: ASRGL1 Target Organism: Homo sapiens (Human) |
|||
Target ID: CHEMBL2094124 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15703381 |
18.4 µM [EC50] | ||
Target ID: P08236 Gene ID: 2990.0 Gene Symbol: GUSB Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/16061593 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
Overview
CYP3A4 | CYP2C9 | CYP2D6 | hERG |
---|---|---|---|
OverviewOther
Other Inhibitor | Other Substrate | Other Inducer |
---|---|---|
Drug as perpetrator
Target | Modality | Activity | Metabolite | Clinical evidence |
---|---|---|---|---|
Sources: https://pubmed.ncbi.nlm.nih.gov/23255614/ Page: - |
no |
Drug as victim
Target | Modality | Activity | Metabolite | Clinical evidence |
---|---|---|---|---|
Sources: https://pubmed.ncbi.nlm.nih.gov/23255614/ Page: - |
no | |||
Page: - |
yes | |||
Page: - |
yes | |||
Page: - |
yes | |||
Sources: https://pubmed.ncbi.nlm.nih.gov/12706335/ Page: - |
yes | |||
Sources: https://pubmed.ncbi.nlm.nih.gov/24147638/ Page: - |
yes |
PubMed
Title | Date | PubMed |
---|---|---|
Ketanserin for the treatment of preeclampsia. | 2001 |
|
Characterization of the protective effects of melatonin and related indoles against alpha-naphthylisothiocyanate-induced liver injury in rats. | 2001 |
|
Metabolism of [1-(13)C)glucose and [2-(13)C]acetate in the hypoxic rat brain. | 2001 Apr |
|
Expression pattern and gene characterization of asporin. a newly discovered member of the leucine-rich repeat protein family. | 2001 Apr 13 |
|
Identification and characterization of asporin. a novel member of the leucine-rich repeat protein family closely related to decorin and biglycan. | 2001 Apr 13 |
|
Phase I and pharmacokinetic study of ecteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignancies. | 2001 Feb |
|
Aging-induced changes in 24-h rhythms of mitogenic responses, lymphocyte subset populations and neurotransmitter and amino acid content in rat submaxillary lymph nodes during Freund's adjuvant arthritis. | 2001 Feb |
|
Differences between GABA levels in Alzheimer's disease and Down syndrome with Alzheimer-like neuropathology. | 2001 Feb |
|
Factors associated with the risk of liver enzyme elevation in patients with type 2 diabetes treated with a thiazolidinedione. | 2001 Feb |
|
Nicotinic receptors mediate the release of amino acid neurotransmitters in cultured cortical neurons. | 2001 Feb |
|
Design, X-ray crystallography, molecular modelling and thermal stability studies of mutant enzymes at site 172 of 3-isopropylmalate dehydrogenase from Thermus thermophilus. | 2001 Feb |
|
Endotoxin clearance and its relation to hepatic and renal disturbances in rats with liver cirrhosis. | 2001 Feb |
|
Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation--role of transjugular intrahepatic portosystemic shunt (TIPS). | 2001 Feb |
|
Extracellular amino acid levels measured with intracerebral microdialysis in the model of posttraumatic epilepsy induced by intracortical iron injection. | 2001 Feb |
|
Serum hepatic biochemical activity in two populations of workers exposed to styrene. | 2001 Feb |
|
Molecular mechanism of action at estrogen receptor alpha of a new clinically relevant antiestrogen (GW7604) related to tamoxifen. | 2001 Feb |
|
Central infusions of the recombinant human prolactin receptor antagonist, S179D-PRL, delay the onset of maternal behavior in steroid-primed, nulliparous female rats. | 2001 Feb |
|
A molecular variant of the APC gene at codon 1822: its association with diet, lifestyle, and risk of colon cancer. | 2001 Feb 1 |
|
DNA-protein crosslinks induced by nickel compounds in isolated rat lymphocytes: role of reactive oxygen species and specific amino acids. | 2001 Feb 1 |
|
Protective effect of stiripentol on acetaminophen-induced hepatotoxicity in rat. | 2001 Feb 1 |
|
Alteration of caspases and apoptosis-related proteins in brains of patients with Alzheimer's disease. | 2001 Feb 16 |
|
Evidence for microvesicular storage and release of glycine in rodent pinealocytes. | 2001 Feb 16 |
|
Phosphorylation-induced change of the oligomerization state of alpha B-crystallin. | 2001 Feb 16 |
|
A novel osteopontin-like protein is expressed in the trout ovary during ovulation. | 2001 Feb 2 |
|
Covariate effects on the apparent clearance of tacrolimus in paediatric liver transplant patients undergoing conversion therapy. | 2001 Jan |
|
Comparison of the efficacy and tolerability of fluvastatin extended-release and immediate-release formulations in the treatment of primary hypercholesterolemia: a randomized trial. | 2001 Jan |
|
Maintenance of primary murine hepatocyte functions in multicomponent polymer capsules--in vitro cryopreservation studies. | 2001 Jan |
|
Relationship between crevicular aspartate aminotransferase levels and periodontal disease progression. | 2001 Jan |
|
Use of intraosseous blood for repeated hematologic and biochemical analyses in healthy pigs. | 2001 Jan |
|
The effect of amino acid-modifying reagents on chloroplast protein import and the formation of early import intermediates. | 2001 Jan |
|
Ehlers-Danlos syndrome type IV with a unique point mutation in COL3A1 and familial phenotype of myocardial infarction without organic coronary stenosis. | 2001 Jan |
|
Effects of aflatoxin and carotenoids on growth performance and immune response in mule ducklings. | 2001 Jan |
|
Lactococcus lactis LM0230 contains a single aminotransferase involved in aspartate biosynthesis, which is essential for growth in milk. | 2001 Jan |
|
Effect of early arterialization of the porcine liver allograft on reperfusion injury, hepatocellular injury, and endothelial cell dysfunction. | 2001 Jan |
|
Redistribution of neuroactive amino acids in hippocampus and striatum during hypoglycemia: a quantitative immunogold study. | 2001 Jan |
|
Excitatory amino acid concentrations in ventricular cerebrospinal fluid after severe traumatic brain injury in infants and children: the role of child abuse. | 2001 Jan |
|
Pregnancy complicated by pre-eclampsia-eclampsia with HELLP syndrome. | 2001 Jan |
|
Possible linkage between glutamate transporter and mitogen-activated protein kinase cascade in cultured rat cortical astrocytes. | 2001 Jan |
|
alpha(2)-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia. | 2001 Jan |
|
The effect of ketamine hydrochloride anesthesia on basal and N-methyl-D,L-aspartate induced plasma prolactin secretion in the adult male rhesus monkey. | 2001 Jan 19 |
|
Three-dimensional structure of Erwinia chrysanthemi pectin methylesterase reveals a novel esterase active site. | 2001 Jan 26 |
|
Simplified technique of orthotopic liver transplantation in pigs. | 2001 Jan 27 |
|
Inhibition of evoked glutamate release by the neuroprotective 5-HT(1A) receptor agonist BAY x 3702 in vitro and in vivo. | 2001 Jan 5 |
|
The effect of repeated gavage doses of fumonisin B1 on the sphinganine and sphingosine levels in vervet monkeys. | 2001 Jul |
|
Stress responses and changes in protein metabolism in carp Cyprinus carpio during cadmium exposure. | 2001 Mar |
|
Association between serum concentrations of hexachlorobenzene and polychlorobiphenyls with thyroid hormone and liver enzymes in a sample of the general population. | 2001 Mar |
|
In vivo evidence for accelerated generation of hydroxyl radicals in liver of Long-Evans Cinnamon (LEC) rats with acute hepatitis. | 2001 Mar 1 |
|
Site-directed mutations in the mitochondrially encoded subunits I and III of yeast cytochrome oxidase. | 2001 Mar 1 |
|
Differential effects of endomorphin-1 and -2 on amphetamine sensitization: neurochemical and behavioral aspects. | 2001 Mar 1 |
|
Pathobiochemical mechanisms involved in the control of the disease caused by Trypanosoma congolense in African grey duiker (Sylvicapra grimmia). | 2001 Mar 5 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3814227
Aspartic acid is a nutrient component found in animal and vegetable sources. In clinical trials to alleviate opioid abstinence it was administered orally.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15703381
Activation of recombinant NMDA receptors was measured using two-electrode voltage clamp. Current and voltage electrodes were made from thin-walled borosilicate glass using a PP-830 electrode puller and when filled with 3 M KCl, possessed resistances of between 0.5 and 1.5 MΩ. Oocytes were voltage-clamped at potentials of -40 mV. Aspartate was able to activate wild type NR1/NR2A NMDA receptors with EC50 of 18.4 uM.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:00:57 GMT 2023
by
admin
on
Fri Dec 15 15:00:57 GMT 2023
|
Record UNII |
30KYC7MIAI
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
1911-7
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
NCI_THESAURUS |
C29596
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
47576-4
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
1914-1
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
30061-6
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
15143-1
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
JECFA EVALUATION |
L-ASPARTIC ACID
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
NCI_THESAURUS |
C68442
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
27256-7
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
22723-1
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
56640-6
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
25865-7
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
15135-7
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
22691-0
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
47574-9
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
1913-3
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
13711-7
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
47573-1
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
22677-9
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
47578-0
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
20639-1
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
26680-9
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
55913-8
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
CFR |
21 CFR 172.320
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
25864-0
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
22655-5
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
25327-8
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
13389-2
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
1912-5
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
DSLD |
2408 (Number of products:573)
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
32232-1
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
47577-2
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
47575-6
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
1915-8
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
44302-8
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
DSLD |
181 (Number of products:10)
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
32231-3
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
||
|
LOINC |
16411-1
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
22660
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
PRIMARY | |||
|
m2100
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
PRIMARY | Merck Index | ||
|
D001224
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
PRIMARY | |||
|
1570
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
PRIMARY | |||
|
CHEMBL274323
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
PRIMARY | |||
|
SUB11721MIG
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
PRIMARY | |||
|
30KYC7MIAI
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
PRIMARY | |||
|
30KYC7MIAI
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
PRIMARY | |||
|
1419
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
PRIMARY | |||
|
SUB32314
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
PRIMARY | |||
|
29995
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
PRIMARY | |||
|
42543
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
ALTERNATIVE | |||
|
ASPARTIC ACID
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
PRIMARY | |||
|
1430
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
PRIMARY | |||
|
C29608
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
PRIMARY | |||
|
DTXSID7022621
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
PRIMARY | |||
|
100000091847
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
PRIMARY | |||
|
72314
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
PRIMARY | |||
|
1550
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
PRIMARY | |||
|
200-291-6
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
PRIMARY | |||
|
17053
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
PRIMARY | |||
|
1043819
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
PRIMARY | |||
|
29958
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
PRIMARY | |||
|
5960
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
PRIMARY | |||
|
DB00128
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
PRIMARY | |||
|
56-84-8
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
PRIMARY | |||
|
1169
Created by
admin on Fri Dec 15 15:00:57 GMT 2023 , Edited by admin on Fri Dec 15 15:00:57 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
MAJOR
PLASMA
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
PARENT -> IMPURITY |
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (TLC)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (TLC)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |